Pirfenidone: In Idiopathic Pulmonary Fibrosis

By Carter Natalie J.  

Drugs, Vol. 71, Iss. 13, 2011-09 ,pp. : 1721-1732

Adis International

Access to resources Recommend Favorite

Inhalation of an endothelin receptor A antagonist attenuates pulmonary inflammation in experimental acute lung injury

By Kalk Philipp   Senf Philine   Deja Maria   Petersen Bodil   Busch Thilo   Bauer Christian   Boemke Willehad   Kaisers Udo   Hocher Berthold  

Canadian Journal of Physiology and Pharmacology, Vol. 86, Iss. 8, 2008-08 ,pp. : 511-515

NRC Research Press

Access to resources Recommend Favorite

Pirfenidone: a guide to its use in idiopathic pulmonary fibrosis

By Keating Gillian M.   Lyseng-Williamson Katherine A.   Carter Natalie J.  

Drugs & Therapy Perspectives, Vol. 28, Iss. 7, 2012-07 ,pp. : 10-13

Adis International

Access to resources Recommend Favorite

Pirfenidone for the treatment of idiopathic pulmonary fibrosis: therapeutic potential prompts further investigation

By Antoniu Sabina A  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 11, 2005-11 ,pp. : 1443-1447

Informa Healthcare

Access to resources Recommend Favorite

Cell- and Isoform-Specific Increases in Arginase Expression in Acute Silica-Induced Pulmonary Inflammation

By Poljakovic Mirjana   Porter Dale   Millecchia Lyndell   Kepka-Lenhart Diane   Beighley Christopher   Wolfarth Michael   Castranova Vincent   Morris Sidney  

Journal of Toxicology and Environmental Health, Vol. 70, Iss. 2, 2007-01 ,pp. : 118-127

Taylor & Francis Ltd

Access to resources Recommend Favorite